Home » N.C. Novartis Site Is First Cell-Based Flu Vaccine Facility in the Country
N.C. Novartis Site Is First Cell-Based Flu Vaccine Facility in the Country
If a flu pandemic strikes the United States, a Novartis plant in North Carolina now stands ready to respond with vaccine techniques that offer speed and scalability advantages over traditional vaccine-making methods.
MedCity News
MedCity News
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May